Why the study?
Does left thoracoscopic sympathectomy prevent arrhythmias in patients with refractory long QT syndrome?
Does left thoracoscopic sympathectomy prevent arrhythmias in patients with refractory long QT syndrome?
Left thoracoscopic sympathectomy appears to be a safe and effective approach for preventing arrhythmias in patients with refractory long QT syndrome.
Supports further evaluation of left thoracoscopic sympathectomy in refractory long QT syndrome; hypothesis-generating and requires larger prospective trials.
Congenital long QT syndrome (LQTS) is a rare genetic disorder that has been associated with various genetic mutations including life-threatening cardiac arrhythmias and sudden death. Left thoracoscopic sympathectomy is an effective treatment for patients who are refractory to medical therapy or who need frequent epicardial internal cardio defibrillator intervention. The authors report three cases, one adult and two children, who underwent successful left thoracoscopic sympathectomy. All three patients remained clinically stable without arrhythmias through 3 months of follow-up. It is suggested in the literature that 77% of patients experienced immediate relief of symptoms. The results of this case report suggest that left thoracoscopic sympathectomy is a safe and effective approach for treating patients with LQTS.
No takes yet. Share an insight, caveat, or question.
Upadya et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: